Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-013407
Filing Date
2022-06-27
Accepted
2022-06-27 17:30:58
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4125
  Complete submission text file 0001567619-22-013407.txt   5684
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVROBIO, INC. ONE KENDALL SQ., BLDG. 300, STE. 201 CAMBRIDGE MA 02139
Business Address
KREHER NERISSA (Reporting) CIK: 0001741850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39683 | Film No.: 221045769